PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 85 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q3 2014. The put-call ratio across all filers is 2.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $585,000 | -29.0% | 941,155 | -48.9% | 0.00% | – |
| Q2 2016 | $824,000 | -56.3% | 1,840,487 | +2.4% | 0.00% | – |
| Q1 2016 | $1,887,000 | -64.3% | 1,796,619 | +0.4% | 0.00% | – |
| Q4 2015 | $5,281,000 | -3.9% | 1,790,106 | +2.9% | 0.00% | – |
| Q3 2015 | $5,498,000 | +1.9% | 1,739,845 | +90.8% | 0.00% | – |
| Q2 2015 | $5,398,000 | -41.1% | 911,728 | +6.4% | 0.00% | -100.0% |
| Q1 2015 | $9,158,000 | +40.7% | 856,759 | +23.6% | 0.00% | – |
| Q4 2014 | $6,508,000 | +35.2% | 693,146 | +10.6% | 0.00% | – |
| Q3 2014 | $4,813,000 | +3.8% | 626,703 | +21.4% | 0.00% | – |
| Q2 2014 | $4,636,000 | +87.3% | 516,284 | +11.6% | 0.00% | – |
| Q1 2014 | $2,475,000 | +149.0% | 462,748 | +17.2% | 0.00% | – |
| Q4 2013 | $994,000 | -7.6% | 394,748 | +0.2% | 0.00% | – |
| Q3 2013 | $1,076,000 | +3.6% | 393,976 | +36.9% | 0.00% | – |
| Q2 2013 | $1,039,000 | – | 287,773 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,134,578 | $10,654,000 | 7.22% |
| Consonance Capital Management LP | 3,427,789 | $32,187,000 | 4.15% |
| ACUTA CAPITAL PARTNERS, LLC | 604,075 | $5,672,000 | 3.83% |
| KOPP INVESTMENT ADVISORS LLC | 758,233 | $7,119,000 | 3.42% |
| Aisling Capital LLC | 2,010,000 | $18,874,000 | 2.86% |
| Broadfin Capital, LLC | 6,100,000 | $57,280,000 | 2.49% |
| THOMPSON DAVIS & CO., INC. | 154,760 | $1,453,000 | 1.68% |
| RUDMAN ERROL M | 300,000 | $2,817,000 | 1.14% |
| WALL STREET ASSOCIATES | 1,259,500 | $11,827,000 | 1.13% |
| Timpani Capital Management LLC | 291,377 | $2,736,000 | 1.08% |